P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic

Detalles Bibliográficos
Autores principales: Lykopoulos, K, Collins, P, Hall, M, Ehness, R, Barth, J, Louahed, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072007/
http://dx.doi.org/10.1186/2051-1426-2-S2-P16
_version_ 1782322888220606464
author Lykopoulos, K
Collins, P
Hall, M
Ehness, R
Barth, J
Louahed, J
author_facet Lykopoulos, K
Collins, P
Hall, M
Ehness, R
Barth, J
Louahed, J
author_sort Lykopoulos, K
collection PubMed
description
format Online
Article
Text
id pubmed-4072007
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40720072014-06-27 P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic Lykopoulos, K Collins, P Hall, M Ehness, R Barth, J Louahed, J J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072007/ http://dx.doi.org/10.1186/2051-1426-2-S2-P16 Text en Copyright © 2014 Lykopoulos et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Lykopoulos, K
Collins, P
Hall, M
Ehness, R
Barth, J
Louahed, J
P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic
title P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic
title_full P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic
title_fullStr P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic
title_full_unstemmed P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic
title_short P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic
title_sort p25. access to diagnostics: a bottleneck for immunotherapeutics development - case example of mage-a3 cancer immunotherapeutic
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072007/
http://dx.doi.org/10.1186/2051-1426-2-S2-P16
work_keys_str_mv AT lykopoulosk p25accesstodiagnosticsabottleneckforimmunotherapeuticsdevelopmentcaseexampleofmagea3cancerimmunotherapeutic
AT collinsp p25accesstodiagnosticsabottleneckforimmunotherapeuticsdevelopmentcaseexampleofmagea3cancerimmunotherapeutic
AT hallm p25accesstodiagnosticsabottleneckforimmunotherapeuticsdevelopmentcaseexampleofmagea3cancerimmunotherapeutic
AT ehnessr p25accesstodiagnosticsabottleneckforimmunotherapeuticsdevelopmentcaseexampleofmagea3cancerimmunotherapeutic
AT barthj p25accesstodiagnosticsabottleneckforimmunotherapeuticsdevelopmentcaseexampleofmagea3cancerimmunotherapeutic
AT louahedj p25accesstodiagnosticsabottleneckforimmunotherapeuticsdevelopmentcaseexampleofmagea3cancerimmunotherapeutic

Ejemplares similares